MedTrace Logo

Nutrition Status, BMD, and SSRIs

NCT03383861 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 13027

Last updated 2024-01-10

No results posted yet for this study

Summary

The association between selective serotonin reuptake inhibitor (SSRI) use and bone mass density (BMD) has been debated. Some have suggested features of depression, which SSRIs are prescribed to treat, may be a cause of decreased BMD, such as poor overall food intake at the time of SSRI use. Our study seeks to determine whether SSRI use in adults is associated with lower than average BMD, and if there is an association between low micronutrient intake, SSRI use, and a low BMD.

Conditions

  • BMD

Interventions

DIAGNOSTIC_TEST

Dual-Energy X-ray Absorptiometry (DXA)

BMD t-score derived from DXA scan

Sponsors & Collaborators

  • University of New Mexico

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-01-31
Primary Completion
2014-12-31
Completion
2014-12-31
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03383861 on ClinicalTrials.gov